Universal Vision Biotechnology Co Ltd (3218.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Services · Taiwan · ISIN TW0003218004

Price
129.50 TWD
Market cap
10.97 bn TWD
P/E (2025)
–
P/S (2025)
2.61
Dividend yield
5.98 %
Net margin
24.80 %
Return on equity (ROE)
25.07 %
Return on assets (ROA)
17.11 %

Universal Vision Biotechnology Co Ltd financials

Fiscal year20242025
Revenue4.23 bn TWD4.20 bn TWD
Gross profit2.53 bn TWD2.48 bn TWD
Operating income1.40 bn TWD1.38 bn TWD
EBIT1.34 bn TWD1.37 bn TWD
Net income1.06 bn TWD1.04 bn TWD

Full history since 2003, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Universal Vision Biotechnology Co Ltd

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides administrative and other professional logistics support services for cooperative clinics and eye centers, as well as brand licensing and consulting services. The company offers its products through its self-operated eyeglasses stores. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.